With chronic stress, behavioral tests, molecular biology, and gene-manipulation approaches, our present study indicated that CD200 in the DG would alleviate depressive-like behaviors in mice via ameliorating the impairment of neurogenesis that was related to the activation of microglia, which may provide a potential target for the treatment of MDD. This evidence concerns the gene CD200 and major depressive disorder.